Skip to main content
ALPS logo

Alps Group Inc

ALPSNASDAQHealthcareBiotechnology

$0.34Today:- (-)1Y −97.74%

As of Oct 16, 2026 close

Market cap
$56.41M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$0.23$12.01
Volume (live)
-
Avg. volume (3M)
50.99K

Alps Group (ALPS) Stock Price & Financial Analysis

Alps Group Stock Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Price & Trading Activity
Day's Range$0.33 - $0.34
52-Week High$12.01
52-Week Low$0.23
Open$0.34
Volume (last close)25.41K
Average Volume (3M)50.99K
Technical Indicators
50-Day MA$0.38
200-Day MA$0.72
1-Year Change−97.74%
Size & Valuation
Market Cap56.41M
Shares Outstanding166.40M
Price to Book (P/B)-19.29
EV/EBITDA-38.62
Dividend Information
Annual Dividend$0.00
Dividend Yield0.00%
Last Dividend Ex-DateFeb 13, 2023

Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology

Compare ALPS with other stocks

Alps Group at a Glance

As of the Oct 16, 2026 close, Alps Group (ALPS) has a market capitalization of $56.41M. Revenue fell 100.0% year over year.

As of its latest reported balance sheet, it holds $607.47K in cash and securities against $2.10M of debt, a net debt position of $1.49M.

Alps Group does not currently pay a dividend.

The share price is down 97.7% over the past year. At $0.34 (the Oct 16, 2026 close) it sits near the bottom of its 52-week range of $0.23 to $12.01, below its 200-day moving average of $0.72.

Frequently Asked Questions About Alps Group

What is the current stock price for ALPS?

As of the Oct 16, 2026 close, ALPS stock trades at $0.34. The 52-week range is $0.23–$12.01, with a day range of $0.33–$0.34.

What is the P/E ratio for ALPS?

The P/E ratio (Price-to-Earnings) for ALPS is shown in the Key Statistics section. This valuation metric helps compare Alps Group Inc to industry peers.

Does ALPS pay dividends?

Alps Group does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.

What do analysts recommend for ALPS?

Analyst ratings and recommendations for ALPS are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of ALPS?

As of the Oct 16, 2026 close, Alps Group's market capitalization is $56.6M, classifying it as a micro-cap company. Alps Group operates in the Healthcare sector within the Biotechnology industry.